Genocea Announces Top-Line Results from Phase 2a Trial for Universal Pneumococcal Vaccine Candidate GEN-004

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/27/2026

1. ON
2. SYNA
3. SPY
4. MU
5. AAPL
6. VEON
7. DRI
8. NVDA
9. FDXF
10. RKLB

Go back to Genocea Announces Top-Line Results from Phase 2a Trial for Universal Pneumococcal Vaccine Candidate GEN-004
GENOCEA BISCNCS (NASDAQ: GNCA) Delayed: 0.05 --0 (-0%)
Previous Close $0.05    52 Week High $8.07 
Open $3.73    52 Week Low $2.56 
Day High $0.05    P/E N/A 
Day Low $0.05    EPS $-2.03 
Volume 50,011